Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
Milliman, Inc., one of the premier global consulting and actuarial firms, announced today that their healthcare analytic platform, MedInsight, has achieved the National Committee for Quality Assurance ...
2025 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators publish new report on CDC and FDA. According to news reporting originating from Honeoye Falls, New ...